Laboratory Monitoring of Oral Anticoagulant Therapy:Are We Being Misled?
Neurol 43:468-470, Albers,G.W., 1993
Computed Tomographic Evidence of an Extensive Thrombosis and Infarction of the Deep Venous System
Stroke 24:744-746, Ur-Rahman,N.&Al-Tahan,A.R., 1993
Oral Contraception and Risk of a Cerebral Thromboembolis Attack:Results of a Case-Control Study
BMJ 306:956-963, Kidegaard,O., 1993
Effect of Low-Intensity Warfarin Anticoag on Level of Activity of Hemostatic System in Pts with Atrial Fib
Stroke 24:1360-1365, Kistler,J.P.,et al, 1993
Safety of Anticoagulation After Hemorrhagic Infarction
Neurol 43:1298-1303, Pessin,M.S.,et al, 1993
Hormone Replacement Therapy and the Risk of Stroke, Follow-up of Population-Based Cohort in Sweden
Arch Int Med 153:1201-1209, Falkeborn,M.,et al, 1993
Complications of Therapy for Venous Thromboembolic Disease in Patients with Brain Tumors
Neurol 43:1111-1114, Levin,J.M.,et al, 1993
Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy
NEJM 329:696-702, Eckman,M.H.,et al, 1993
Estrogen Replacement Therapy and Cognitive Function in Older Women
JAMA 269:2637-2641, Barrett-Conner,E.&Kritz-Silverstein,D., 1993
The Management of Acute Visual Failure
JNNP 56:234-240, Wray,S.H., 1993
Epilepsy and Pregnancy
BMJ 307:492-495, O'Brien,M.D.&Gilmour-White,S., 1993
Anticoagulant-Related Bleeding:Clinical Epidemiology, Prediction, and Prevention
Am J Med 95:315-328, Landefeld,C.S.&Beyth,R.J., 1993
Deep Cerebral Venous System Thrombosis:Case Report
Neurosurgery 33:911-913, Brown,J.I.M.,et al, 1993
How Twin Cities Neurologists Treat Ischemic Stroke, Policies and Trends
Arch Neurol 50:1098-1103, Anderson,D.C., 1993
The Efficacy & Safety of Ticlopidine & Aspirin in Non-Whites:Subgroup from Ticlopidine Aspirin Stroke Study
Neurol 43:27-31, Weisberg,L.A., 1993
Antithrombotic Therapy in Acute Ischaemic Stroke:An Overviews of the Completed Randomized Trials
JNNP 56:17-25, Sandercock,P.A.G.,et al, 1993
Risk Factors for Complications of Chronic Anticoagulation
Ann Int Med 118:511-520, Fihn,S.D.,et al, 1993
Cost Effectiveness of Primary Stroke Prevention in Atrial Fibrillation
BMJ 305:1457-1460, 14451992., Gustafsson,C.,et al, 1992
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
NEJM 327:1406-1412, 14511992., Ezekowitz,M.D.,et al, 1992
Anticoagulant Treatment as a Risk Factor for Primary Intracerebral Hemorrhage
JNNP 55:1121-1124, Fogelholm,R.,et al, 1992
Failure of High-Dose Heparin to Prevent Recurr Cardioembolic Strokes in Preg Pt with Mech Heart Valve
Neurol 42:2204-2206, Golby,A.J.,et al, 1992
Stroke Complic Acute MI, A Meta-Analysis of Risk Modific by Antigoac & Thrombolytic Therapy
Arch Int Med 152:2020-2024, Viatkus,P.T.,et al, 1992
Cerebral Venous Thrombosis
Neurol Clin 10:87-111, Ameri,A.&Bousser,M-G., 1992
Ticlopidine vs Aspirin for Prevention of Recurrent Stroke, Analysis of Pts with Stroke from Ticlopidine Aspirin Study
Stroke 23:1723-1727, Harbison,J.W., 1992
Effects of Low-to-High Doses of Aspirin on Platelet Aggregab & Metabol of Thromboxane A2 & Prostacyclin
Stroke 23:1400-1403, Tohgi,H.,et al, 1992
Low-Dose Aspirin and Stroke"It Ain't Necessarily So"
Stroke 23:1395-1399, Dyken,M.L.,et al, 1992
Reliance on Prothrombin Time Ratios Causes Significant Errors in Anticoagulation Therapy
Arch Int Med 152:278-282, 2571992., Bussey,H.I.,et al, 1992
Cerebral Venous Thrombosis in Behcet's Disease:Clinical Study and Long-Term Follow-Up of 25 Cases
Neurol 42:614-618, Wechsler,B.,et al, 1992
Secondary Prevention of Stroke
Lancet 339:724-727, Warlow,C., 1992
Predictors of Thromboembolism in Atrial Fibrillation:I. Clinical Features of patients at Risk
The Stroke Prevention in A Fib Investigators, Ann Int Med 116:1-51992., , 1992
Cardiogenic Embolism to the Brain
Lancet 339:589-594, Hart,R.G., 1992
Role of Ticlopidine for Prevention of Stroke
Stroke 23:912-916, Albers,G.W., 1992
European Stroke Prevention Study:Effectiveness of Antiplatelet Therapy in Diabetics in Secondary Prevent of Stroke
Stroke 23:851-854, Sivenius,J.,et al, 1992
Cheiro-Oral Syndrome Due to Lesions in the Corona Radiata
Stroke 23:599-601, Omae,T.,et al, 1992
Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992
Emergency Reversal of Anticoagulation aftr Intracerebral Hemorrhage
Stroke 23:972-977, Fredriksson,K.,et al, 1992
Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992
A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992
Prevention of Stroke with Ticlopidine:Who Benefits Most?
Neurol 42:111-115, Grotta,J.C.,et al, 1992
Acute Compartment Syndromes Resulting from Anticoagulant Treatment
BMJ 305:1474-1475, Hay,S.M.,et al, 1992
Venous Thromboembolism in Stroke:Literature Review and Implications for Clinical Practice
Arch Phys Med Rehabil 73:379-391, Brandstater,M.E.,et al, 1992
Phase I Clinical and Pharmacological Study of Chloroquinoxaline Sulfonamide
Cancer Research 452:6619-6623, Rigas,J.R.,et al, 1992
Role of Prophyl Anticoag for Direct Current Cardiover in Pts with Atrial Fib, Atrial Flutter
J Am Coll Cardiol 19:851-855, Zeiler,A.,et al, 1992
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg/day) in Pats. After a TIA or Minor Ischemic Stroke
Dutch TIA Trial Study Group, NEJM 325:1261-1266, 1303991., , 1991
Swedish Aspirin Low-Dose Trial (SALT) of 75 mg Aspirin as Secondary Prophylaxis After Cerebrovascular Ischaemic Events
The SALT Coll Group, Lancet 338:1345-13491991., , 1991
Dissection of the Extracranial Vertebral Artery:Report of Four Cases and Review of the Literature
JNNP 54:863-869, Hinse,P.,et al, 1991
Ticlopidine
Editorial, Lancet 337:459-4601991., , 1991
Thrombotic Thrombocytopenic Purpura Related to Ticlopidine
Lancet 337:774-776, Page,Y.,et al, 1991
Heparin Treatment in Sinus Venous Thrombosis
Lancet 338:597-600, Einhaupl,K.M.,et al, 1991
Intracerebral Hemorrhage
Stroke 22:684-691, Feldmann,E., 1991